Prescription of antiepileptic medicines including valproate in pregnant women: A study in three European countries.

Caroline Hurault-Delarue Joan K MorrisRachel CharltonRosa GiniMaria LoaneAnna PieriniAurora PucciniAmanda NevilleJulia SnowballChristine Damase-Michelnull null

Published in: Pharmacoepidemiology and drug safety (2019)

Variations in AED prescribing during pregnancy indicate the potential for further reductions, particularly of valproate. Increases in pregabalin/gabapentin prescribing, for which risks are not well known, are a cause for concern.

Keyphrases

pregnant women
primary care
neuropathic pain
human health
adverse drug
risk assessment
spinal cord injury
pregnancy outcomes